Form 8-K - Current report:
SEC Accession No. 0001193805-26-000214
Filing Date
2026-03-03
Accepted
2026-03-03 16:05:54
Documents
13
Period of Report
2026-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e665201_8k-arct.htm   iXBRL 8-K 27054
2 e665201_ex99-1.htm EX-99.1 68903
  Complete submission text file 0001193805-26-000214.txt   271516

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE arct-20260303.xsd EX-101.SCH 3020
4 XBRL LABEL FILE arct-20260303_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE arct-20260303_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT e665201_8k-arct_htm.xml XML 3119
Mailing Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA
Business Address 10285 SCIENCE CENTER DRIVE SAN DIEGO CA 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 26713950
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)